TransMed 2019

From TransMed
Revision as of 19:36, 9 May 2019 by 3fgqxs (Talk | contribs) (Contact us)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Description

Knowledge-based translational medicine is a rapidly growing discipline in biomedical research and aims to expedite the discovery of new diagnostic tools and treatments by using a multi-disciplinary, highly collaborative, "bench-to-bedside" approach. Large amounts of multi-omics, imaging (medical and molecular) and clinical data can now be captured for given patient populations. In addition to the challenges of data curation and harmonisation, new computational methods are required to identify molecular signatures that suggest disease subtype. These signatures may be predictive of outcome or progression, and impact on disease management by suggesting personalised therapeutic strategies for patients. Such approaches will further the development of a new taxonomy of disease.

In the TransMed COSI meeting, we will explore the current status of computational biology approaches within the field of translational medicine.

Information of previous TransMed meeting(s) can be found here.

Link to the ISMB/ECCB 2019 website is: here

Please note:

  • The TransMed COSI meeting will take place on July 21th-25th, 2019, during the ISMB/ECCB 2019, Basel, Switzerland.


Topics of interest

Topics of interest include, but are not limited to:

  • Clinical and molecular data storage and integration infrastructure, including: data warehousing for translational medicine, multi-‘omics and clinical data integration, data visualization in translational medicine
  • Curation and harmonization of clinical, ‘omics and imaging data, including: standards and ontologies in translational medicine, biomedical text mining and semantic representation
  • Data analytics for patient stratification, biomarker and target discovery, including: disease subtype discovery, Electronic Health Records integration, translational imaging, multi-scale modelling, high performance and cloud computing in translational medicine, mathematical modelling for disease processes, pathways and networks
  • Computational approaches for target selection and drug discovery, including: druggability assessment and target selection, polypharmacology, drug reuse, chemical library design, virtual screening technologies, drug discovery enabler pipelines and databases, chemical tool analysis.
  • ADME/PK and Tox models, including: databases and modeling approaches for ADME and PK, machine learning approaches to predicting toxicity, modeling of pharmacokinetics to man and model organism utility models.
  • Translational Medicine Informatics Applications/Case Studies, including: Next generation sequencing annotation and biomedicine applications, clinical data integration and application.

Keynote speakers

Isaac Kohane, Department of Biomedical Informatics, Harvard Medical School

Keynote title: Five ways computational biologists can accelerate medicine

Charles Mayo, University of Michigan

Bissan Al-Lazikani, The Institute of Cancer Research

Keynote title: Harnessing Big, Multidisciplinary Data to Inform Cancer Medicine

Agenda

Start time End time Topic
10:15 12:40 Chair: TBD
17:50 18:00 Concluding Remarks- TBD

Abstract submission

Authors are invited to submit abstracts (1 page) for presentations and posters by TBD, 2019. Acceptance notification will be sent out by TBD, 2019.

For proceedings submission the deadline is Monday, January 28, 2019

Please use the [TBD EasyChair] submission system: TBD .

Key dates

  • Detail information can be found: here.

Venue

The TransMed COSI meeting will take place on July 21th-25th, 2019, during the ISMB/ECCB 2019, Basel, Switzerland.

Sponsorship

We would like to thank our sponsors:

for their kind support:


Registration

Please follow the registration page on the ISMB website: TransMed COSI Registration.

Organizing committee

Venkata Satagopam, Luxembourg Centre For Systems Biomedicine (LCSB), University of Luxembourg, Luxembourg

Bissan Al-Lazikani, The Institute of Cancer Research, London, UK

Reinhard Schneider, Luxembourg Centre For Systems Biomedicine (LCSB), University of Luxembourg, Luxembourg

Maria Secrier, University College London, UK

Wei Gu, Luxembourg Centre For Systems Biomedicine (LCSB), University of Luxembourg, Luxembourg

Mansoor Saqi, King’s College London, UK

Irina Balaur, European Institute for Systems Biology and Medicine, Lyon, France

Programme committee (alphabetical order)

TBD, TBD

Xuefeng Cui, Tsinghua University, China
Xiaoke Hao, Hebei University of Technology, China
Chaochun Wei, Shanghai Jiao Tong University, China

Contact us

If you have any questions, please do not hesitate to contact us: transmed-cosi-chair@googlegroups.com.

Follow us

Google Groups: TransMed2019 Google Group

Twitter: #TransMed2019

Linkedin: Translational Medicine Informatics & Applications Group

Acknowledgement

The current TransMed logo was designed by Belinda Hanson.

The previous TransMed logo was designed by Alexandre Pellet, www.alexandrepellet.com.